RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres
NCT ID: NCT03416114
Last Updated: 2018-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2017-09-01
2027-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
(Italian Migraine Registry, I-GRAINE-NEW)
NCT07163416
Brain Perfusion Assessment in the Acute Phase of Migraine Aura
NCT03821584
Migraine Attack Pain Phase Prediction Study
NCT06459635
Study of the Glymphatic System in Migraine
NCT05907655
Rate , Predictors and Outcome of Chronic Migraine
NCT05079659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients who have received or will receive a diagnosis of rare primary headache will be asked to participate and, to this aim, to give their informed consent. Each participating Centre should have received the approval of the competent Ethics Committee before commencing any study procedures.
The registry will contain anagraphic information and data about diagnosis, treatment, comorbidity, and clinical features of the headache. Patients' data will be coded through the Italian Health System unique identifier, in order to avoid duplications of patients referring to more than one Centre and also to monitor multiple referrals.
A web-based open source platform (SurveyMonkey.org) will be used to collect data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed informed consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Modena and Reggio Emilia
OTHER
University of Roma La Sapienza
OTHER
University of Naples
OTHER
University of Trieste
OTHER
Maggiore Bellaria Hospital, Bologna
OTHER
University of L'Aquila
OTHER
Silvia Benemei
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silvia Benemei
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silvia Benemei, MD
Role: STUDY_CHAIR
Careggi University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Careggi University Hospital
Florence, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Silvia Benemei, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lupi C, Evangelista L, Favoni V, Granato A, Negro A, Pellesi L, Ornello R, Russo A, Cevoli S, Guerzoni S, Benemei S. Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network. Cephalalgia. 2018 Jul;38(8):1429-1441. doi: 10.1177/0333102418768824. Epub 2018 May 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RegistRare
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.